In this case study, you would learn how Syngene enabled a hybrid, device-based IPF cough trial in India for a clinical-stage pharma company—delivering seamless formulation-to-site execution with robust data integrity, regulatory navigation, and on-time delivery.
Hybrid, device-enabled IPF cough trial for a Swedish sponsor— integrated formulation-to-site execution by Syngene
